Effectiveness of tofacitinib in patients with ulcerative colitis: an updated systematic review and meta-analysis of real-world studies
Objectives This study aimed to evaluate the real-world effectiveness of tofacitinib for treating moderate-to-severe ulcerative colitis (UC).Design Systematic review and meta-analysis.Data sources PubMed, EMBASE and Cochrane CENTRAL databases were searched from inception up to 18 July 2023. Reference...
Saved in:
| Main Authors: | Chuan Wan, Chien-Hung Lin, Wen-Sheng Liu, Hsin-Hui Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-12-01
|
| Series: | BMJ Open Gastroenterology |
| Online Access: | https://bmjopengastro.bmj.com/content/11/1/e001347.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation
by: Emily Wright, et al.
Published: (2019-08-01) -
Correction: Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation
Published: (2020-12-01) -
Impact of biological agents and tofacitinib for moderate-to-severe ulcerative colitis on health-related quality of life: a protocol for a network meta-analysis
by: Xueni Ma, et al.
Published: (2021-12-01) -
Efficacy And Safety Of Low Dose Tofacitinib As Induction Therapy In Moderate To Severe Ulcerative Colitis: A Pilot Study
by: Sadia Ahmed, et al.
Published: (2024-12-01) -
Efficacy and safety of tofacitinib in rheumatoid arthritis: Nine years of real‐world data
by: Ali Ekin, et al.
Published: (2024-11-01)